Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Vanda Pharmaceuticals buy StockNews.com

Start price
€3.92
30.03.24 / 50%
Target price
-
30.03.25
Performance (%)
-2.04%
Price
€3.84
11:29
Summary
This prediction is currently active. With a performance of -2.04%, the BUY prediction by StockNews_com is trending in the wrong direction. This prediction currently runs until 30.03.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this prediction
Performance without dividends (%)
Name 1w
Vanda Pharmaceuticals -10.314%
iShares Core DAX® -1.828%
iShares Nasdaq 100 1.311%
iShares Nikkei 225® 0.586%
iShares S&P 500 0.241%

Comments by StockNews_com for this prediction

In the thread Vanda Pharmaceuticals diskutieren

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for VNDA provided by MarketBeat

Stopped prediction by StockNews_com for Vanda Pharmaceuticals

buy
Vanda Pharmaceuticals

Start price
Target price
Perf. (%)
€3.86
14.04.24
-
14.04.25
-0.52%
11:29

buy
Vanda Pharmaceuticals

Start price
Target price
Perf. (%)
€5.25
29.07.23
-
29.07.24
-26.86%
11:29

buy
Vanda Pharmaceuticals

Start price
Target price
Perf. (%)
€5.90
04.03.23
-
04.03.24
-34.24%
05.03.24